U.S. Physical Therapy, Inc. (USPH) — Fair Value Analysis

Base-case fair value (P50): $59.97 · Current price: $59.29 · Verdict: Fairly Valued

The Verdict on USPH

Based on Monte Carlo simulations, US PHYSICAL THERAPY INC (USPH) is currently deemed Fairly Valued. With a current price of $59.29, our analysis indicates a median fair value (P50) of $59.97, representing a modest +1.1% difference from its trading level. This narrow margin suggests that USPH is trading very close to its intrinsic worth, according to thousands of forward scenarios simulated by our models. While a slight upside exists to reach the median fair value, the simulations do not indicate significant overvaluation or undervaluation at the current $59.29 price point. This tight convergence between the current price and the median fair value is a key takeaway from our latest assessment.

How USPH stacks up against peers

When evaluating US PHYSICAL THERAPY INC's market position, its quality tier is an important consideration. The company is assessed as having "average" operational and financial health relative to its sector peers. This "average" quality tier, alongside a current price of $59.29 and a median fair value of $59.97, paints a picture of a company whose valuation is largely aligned with its fundamental standing. The +1.1% difference to the P50 fair value is consistent with an "average" quality company that isn't experiencing significant market mispricing based on its financial and operational metrics compared to the broader sector. An "average" quality company trading at a price close to its median fair value suggests the market has appropriately discounted its current operational and financial health.

What this means for investors

For investors considering US PHYSICAL THERAPY INC, the "Fairly Valued" verdict signals that the market price of $59.29 closely reflects its intrinsic value, with a median fair value (P50) of $59.97 indicating only a +1.1% upside to this central estimate. This implies that significant arbitrage opportunities, whether in a bull or bear case, are not immediately evident based on the median scenario. Given USPH's "average" quality tier, its current valuation appears rational within its sector context. The FairCurve simulations, anchoring this assessment, highlight the current equilibrium. To explore the full distribution of potential outcomes for USPH, including the bear (P10) and bull (P90) targets, sign up for a free FairCurve account and track USPH's fair value as new fundamentals are released.